cysteine has been researched along with melphalan in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, S; Aljian, J; Okine, L; Vistica, DT; Wood, R | 1 |
| Ahmad, S; Le, B; Najarian, P; Okine, L; Vistica, DT | 1 |
| Donelli, MG; Garattini, S; Rosso, R | 1 |
| Dietze, F; Lisewski, G; Reitzig, P; Schulz, HJ | 1 |
| Ball, CR; Connors, TA | 1 |
| Fenselau, C; Wu, Z; Yu, X | 1 |
| Cherian, MG; Imura, N; Satoh, M; Shimizu, H | 1 |
| Fenselau, C; Szilágyi, Z | 1 |
| Hulst, AG; Jansen, R; Noort, D | 1 |
| Colombo, G; Corti, A; Curnis, F; De Mori, GM; Gasparri, A; Longhi, R; Longoni, C; Sacchi, A | 1 |
| CALCUTT, G; CONNORS, TA; ELSON, LA; ROSS, WC | 1 |
| Kong, FL; Yang, DJ; Young, DP; Yu, DF; Zhang, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and melphalan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for cysteine and melphalan
| Article | Year |
|---|---|
gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.
Topics: Alkylating Agents; Animals; Cell Line; Cysteine; Drug Resistance; Ethylmaleimide; gamma-Glutamyltransferase; Glutamates; Kinetics; Leukemia L1210; Melphalan; Mice; Sulfhydryl Compounds | 1987 |
Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells.
Topics: Animals; Cysteine; Dipeptides; Drug Resistance; Glutathione; Glutathione Disulfide; Kinetics; Leukemia L1210; Melphalan; Mice | 1987 |
On the neurotoxic effects induced by alkylating agents.
Topics: Alanine; Animals; Anti-Bacterial Agents; Antimetabolites; Azaserine; Behavior, Animal; Central Nervous System; Chlorambucil; Cyclophosphamide; Cysteine; Drug Antagonism; Glycine; Male; Mannitol; Mechlorethamine; Melphalan; Nitrogen Mustard Compounds; Phenobarbital; Phenytoin; Rats; Seizures; Spasm; Thiourea; Triethylenemelamine; Tryptophan | 1966 |
[Malabsorption syndrome and intestinal pseudoobstruction in primary vascular and heart amyloidosis].
Topics: Adult; Amyloidosis; Antibody Formation; Antigen-Antibody Complex; Azathioprine; Chloramphenicol; Cysteine; Heart Diseases; Humans; Intestinal Obstruction; Malabsorption Syndromes; Male; Melphalan; Penicillamine; Prednisone; Time Factors; Vascular Diseases | 1973 |
Reduction of the toxicity of "radiomimetic" alkylating agents by thiol pretreatment. VI. The mechanism of protection by cysteine.
Topics: Alkylation; Animals; Cysteine; Cytoplasm; DNA; Female; Glutathione; Melphalan; Proteins; Rats; RNA; Sarcoma, Yoshida; Thiosulfates; Tritium | 1967 |
Covalent sequestration of melphalan by metallothionein and selective alkylation of cysteines.
Topics: Alkylation; Amino Acid Sequence; Animals; Binding Sites; Cysteine; Drug Resistance; Hydrogen-Ion Concentration; In Vitro Techniques; Liver; Melphalan; Metallothionein; Molecular Sequence Data; Molecular Structure; Peptide Fragments; Rabbits; Spectrometry, Mass, Fast Atom Bombardment | 1995 |
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibrosarcoma; Glycine; Humans; Male; Melphalan; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Pargyline; Sulfates; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Zinc Compounds; Zinc Sulfate | 1994 |
Molecular dynamics simulation of metallothionein-drug complexes.
Topics: Binding Sites; Chemical Phenomena; Chemistry, Physical; Chlorambucil; Computer Simulation; Crystallography, X-Ray; Cysteine; Mechlorethamine; Melphalan; Metallothionein; Models, Structural; Nitrogen Mustard Compounds; Protein Binding; Zinc | 2000 |
Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.
Topics: Binding Sites; Chlorambucil; Cyclophosphamide; Cysteine; Drug Monitoring; Humans; In Vitro Techniques; Mechlorethamine; Melphalan; Nitrogen Mustard Compounds; Protein Binding; Serum Albumin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2002 |
Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif.
Topics: Amino Acid Motifs; Animals; Arginine; Asparagine; Binding, Competitive; Blotting, Western; Cysteine; Disulfides; Glycine; Humans; Immunohistochemistry; Kinetics; Melphalan; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Peptides; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Structure-Activity Relationship; Temperature; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. II. MECHANISM OF PROTECTION.
Topics: Alkylating Agents; Cysteine; Melphalan; Nitrogen Mustard Compounds; Pharmacology; Rats; Research; Sulfhydryl Compounds; Toxicology | 1963 |
Development of (99m)Tc-EC-tyrosine for early detection of breast cancer tumor response to the anticancer drug melphalan.
Topics: Amino Acid Transport System y+L; Animals; Breast Neoplasms; Chelating Agents; Cysteine; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Ki-67 Antigen; Melphalan; Neoplasm Proteins; Organotechnetium Compounds; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution; Treatment Outcome; Tyrosine | 2013 |